After months spent pursuing a plan to convert itself into a for-profit business, OpenAI is reversing course and said Monday ...

Positive Lexeo Therapeutics, Inc. interim data from SUNRISE-FA study highlights LX2006's potential for Friedreich's Ataxia.

Tim Friede has been bitten by hundreds of snakes. And now, scientists are studying his blood to create a universal antivenom.

Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the ...

Japan continues to pace like-minded governments when making economic security policy. Successive administrations in Tokyo ...

Using relational risk analysis, let's take a closer look at risk management plans for identifying and managing adverse ...

IMPROVING THE SAFETY AND SECURITY OF BIOLOGICAL RESEARCH By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.

CareTrust REIT's acquisition of Care REIT will drive portfolio growth in the UK region. Read why I reaffirm my prior buy ...

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision ...

Viatris Inc. , a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, Frank ...

SNS Insider Report Highlights 10.45% CAGR from 2024 to 2032 as Pharma, Biotech, and CROs Intensify Outsourcing of Medical Writing Services.Austin, May 05, 2025 (GLOBE NEWSWIRE) -- Global Medical ...

A panelist discusses how the evolving landscape of atopic dermatitis treatment is moving toward a more personalized approach that carefully balances efficacy goals with safety considerations, ...